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ABSTRACT
Objectives: To compare the surgical and immediate post-
operative outcomes for vaginal hysterectomy (VH) with
those for laparoscopically assisted vaginal hysterectomy
(LAVH) in patients with enlarged myomatous uterus.
Methods: Eighty women requiring hysterectomy for an
enlarged myomatous uterus were randomly allocated into
2 treatment arms: VH (n40) and LAVH (n40). The
randomization procedure was based on a computer-gen-
erated list. The primary outcome was a comparison of the
discharge times between the 2 procedures. Continuous
outcome variables were analyzed using the Student t test.
Discrete variables were analyzed with the chi-square test
or Fisher’s exact test. P0.05 was considered statistically
significant.
Results: The mean discharge time was longer for LAVH
than for VH (724.2 vs 482.6 h; P0.00). VH resulted in
shorter times for paralytic ileus (193v s2 6 3h ;P 0.00)
and surgery (713v s1 2 9 7 min; P0.00). The intraop-
erative blood loss was less with VH (186.052 vs
362.765 mL; P0.00). No intraoperative complications
occurred, and no patient was returned to the operative
theater in either group.
Conclusions: Several surgical and immediate postopera-
tive outcomes were significantly better in the VH group
than in the LAVH group. However, further controlled
prospective studies are required for identifying the best
approach for hysterectomy in patients with enlarged
uterus.
Key Words: Enlarged uterus, Uterine myomas, Vaginal
hysterectomy, Laparoscopically assisted vaginal hysterec-
tomy.
INTRODUCTION
Hysterectomy is a major gynecological operative proce-
dure that is often performed for symptomatic leiomyomas.
However, there is no universal agreement among gyne-
cologists about the optimal method of hysterectomy in
patients with an enlarged myomatous uterus. Generally,
the surgical route for hysterectomy is selected on clinical
and technical factors, such as uterine weight or previous
vaginal deliveries.1 In the studies comparing the operative
techniques of hysterectomy in patients with enlarged
uteri, it has been documented that vaginal hysterectomy
(VH) offers significant benefits in terms of reduced hos-
pital stay and more rapid recuperation compared with
abdominal hysterectomy (AH).2–4 VH was associated with
significantly shorter operating time and lower costs with
no detectable difference in quality of life measures or
complication rates.5,6 Laparoscopically assisted vaginal
hysterectomy (LAVH) resulted in less postoperative pain
and a shorter hospital stay compared with AH.7,8 How-
ever, LAVH resulted in increased operating time and
blood loss, and it was more expensive than VH or AH.8–11
In the literature, few randomized trials compare the op-
erative and early postoperative outcomes for VH with
those for LAVH.6,8,9,12 Therefore, our randomized trial
aimed to compare the surgical and immediate postoper-
ative outcomes of vaginal hysterectomy (VH) with those
of laparoscopically assisted vaginal hysterectomy (LAVH)
in a series of patients with symptomatic myomas and
enlarged uteri.
METHODS
Patients
The trial was performed at the Section of Gynaecology,
Department of Surgery, Tor Vergata University Hospital,
Rome. From April 2003 to June 2005, all women with
symptomatic uterine myomas requiring hysterectomy
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SCIENTIFIC PAPERwere considered eligible for the study. Inclusion criteria
were1 presence of symptomatic or rapidly growing myo-
mas2; age 55 years3; uterine size 12 weeks gestation.
Exclusion criteria were1 nulliparous women2; uterine size
16 weeks gestation3; previous uterine surgery4; suspect
malignant gynecological disease.
The local ethics committee previously approved this
study, and the Italian Ministry of Education provided re-
search funds. None of the authors have a financial interest
in or any arrangement with the companies producing the
instruments used in the study or with competing compa-
nies. There also was no direct payment to the authors
from any source for the purpose of financing the writing
of the manuscript, nor were there any other financial
connections, direct or indirect, or other situations that
might raise the question of bias in the work.
Of the 145 women requiring hysterectomy, 89 fulfilled the
inclusion criteria and were recruited for the trial. Nine
refused to participate. A written informed consent was
obtained from each patient before randomization. The
enrollment was closed when 80 patients were included,
and 40 patients were allocated to each group. The patients
were randomized the day before surgery. The randomiza-
tion procedure was based on a computer-generated list
using serially numbered, opaque, sealed envelopes. A
blinded physician randomly assigned each patient to ei-
ther VH (n  40) or LAVH (n  40). The sequence was
concealed until interventions were assigned. Those who
performed surgical procedures did not know which pa-
tients undergoing surgery had been included in the study.
Those assessing the outcomes were blinded to the group
assignments.
All procedures were performed by the same surgeons (EP,
FS) using the same technique. Standard preoperative as-
sessment was performed together with an abdominal and
transvaginal ultrasound to estimate the size, the number,
the site of the myomas, and the uterine size. Intraoperative
prophylactic antibiotic therapy by an ampicillin sodium/
sulbactam sodium combination was administered to all
the patients. Gonadotropin-releasing hormone agonists
(GnRH-a) were never administered.
Surgical Technique
VH was carried out as described by Dargent.13 After de-
taching the ventral vaginal wall and mobilizing the blad-
der, an incision was made in the so-called bladder groove;
the supravaginal septum was divided in order to reach the
utero-vesical space, avoiding opening the peritoneum at
this stage. Successively, after detaching the dorsal vaginal
wall and entering the pouch of Douglas, a posterior col-
potomy was made, and the “posterior supravaginal sep-
tum” was opened entering the peritoneal pouch of Doug-
las. A gaze roll was placed in the peritoneal cavity to avoid
descent of the intestinal loops. After protecting the blad-
der in front and the rectum behind, the broad ligaments
were divided. The paracervical or suspensory ligaments
(that include the lower part of the bladder pillar, parame-
trium, and uterosacral ligament) were identified and su-
tured before dividing. The utero-vesical peritoneal fold
was opened. Adnexal pedicles were clamped and divided.
If at this time the uterine size did not allow easy exterior-
ization, bisecting, coring, morcellation, enucleation of my-
omas, or combinations of these volume-reducing tech-
niques were performed.14 Finally, the vagina was closed,
while at the same time approximating the pedicle stumps
of the suspensory ligaments.
LAVH was performed at type ID (dissection up to but not
including uterine arteries  anterior structures and poste-
rior culdotomy) of laparoscopic assistance, according to
the AAGL Classification System for Laparoscopic Hyster-
ectomy.15 A uterine manipulator was placed into the
uterus. Laparoscopy was performed with a 10-mm princi-
pal trocar introduced through the umbilicus. Under direct
visualization, 2 lower incisions lateral to the rectus mus-
cles were executed placing 2 ancillary 5-mm trocars. The
operation began with the dissection of bilateral round
ligaments and adnexa. After the course of ureters was
identified, the round ligaments were grasped with a bipo-
lar forceps, 2 cm to 3 cm distal to their uterine insertion,
and desiccated for a length of about 1.5 cm. This desic-
cated area was divided with scissors. If adnexa were to be
conserved, hemostasis and dissection of the ovarian liga-
ments were performed. If the tubes and ovaries were to be
removed with the uterus, the infundibulopelvic portion of
the broad ligaments was coagulated and dissected. The
anterior fold of the broad ligaments was opened and
incised using scissors at the level of the vesico-uterine
pouch. The posterior leaf of the broad ligament was cut
on each side, parallel to the lateral side of the uterus,
down to the point of origin of the uterosacral ligaments
behind the cervix. The subsequent steps were performed
vaginally. A circular colpotomy was carried out by means
of a scalpel. The cardinal and uterosacral ligaments, and
the uterine vessels were clamped, cut, and sutured. The
detached uterus was removed vaginally. When required, a
combined vaginal bisection, coring, morcellation, and
myomectomy was performed. After the closure of the
vaginal cuff, pneumoperitoneum was re-established, and
all pedicles were inspected to ensure hemostasis.
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between the 2 procedures in terms of discharge time.
Discharge time was chosen as a primary outcome because
it is generally influenced by the main operative data (op-
erative time, blood loss, paralytic ileus time, early postop-
erative complications). Discharge time was measured in
hours after surgery. The patients were discharged from the
hospital when they were tolerant of a normal diet, able to
dress themselves, fully mobile, apyrexial, and not requir-
ing analgesics. The secondary outcome measures were
differences in operation time, blood loss, paralytic ileus
time, febrile morbidity (body temperature 38°C in 2
consecutive measurements  4 hours apart), intensity of
pain, early postoperative complications (any unfavorable
episode occurring within 30 days after surgery requiring
readmission, blood transfusion, or repeat surgery).
The operation time was calculated from skin or vaginal
incision to closure. Blood loss was estimated by calculat-
ing the blood volume of the suction machine during
surgery, excluding liquid utilized for intraperitoneal wash-
ing, and by weighing swabs. Paralytic ileus time was
calculated in hours from the end of the procedure to the
ability to pass stool or gas. Postoperative pain was as-
sessed at 24 hours by using a visual analog scale (VAS)
that consisted of a nongraduated 10-cm line ranging from
0 (no pain) to 100 (pain as bad as it could be). Women
were subdivided into 5 categories: absence of pain
(VAS0); mild pain (VAS1 to 25); moderate pain
(VAS26 to 50); severe pain (VAS51 to 75); and very
severe pain (VAS76 to 100).
Statistical Analysis
A power calculation verified that more than 26 patients in
each group would be necessary to detect a difference of
more than 24 hours in discharge time with an alpha error
level of 5% and a beta error of 80%. Statistical analysis was
performed using the Statistical Program/SPSS for Win-
dows, version 10 (Chicago, IL, USA). Continuous outcome
variables were analyzed using the Student t test. Discrete
variables were analyzed using the chi-square test or Fish-
er’s exact test. The 2 treatment groups were compared
using a one-way analysis of variance (ANOVA) followed
by Tukey’s HSD for post hoc comparison of the mean
values. A general linear model (GLM) procedure also was
used to investigate interactions between variables (regres-
sion analysis). P0.05 was considered statistically signif-
icant.
RESULTS
Age, BMI, parity, uterine weight, and symptoms were
similar in the 2 groups (Table 1). Procedures were suc-
cessfully performed for all the patients in both groups.
Table 2 shows the operative parameters in the 2 groups.
The mean operating time was significantly shorter after
VH than after LAVH (713v s1 2 9 7 min; P0.00). The
intraoperative blood loss had an influence on the operat-
ing time considered as a dependent variable in the GLM
analysis (P0.02), and this effect was particularly strong
for LAVH (P0.00). On the contrary, uterine weight did
not have any effect on the operating time considered a
dependent variable in the GLM analysis (P0.50). Intra-
operative blood loss was less than with VH (186.052 vs
362.765 mL; P0.00). Uterine weight did not have any
effect on the blood loss considered as a dependent vari-
able in the GLM analysis (P0.05). No intraoperative com-
plications occurred, and no case was returned to the
theater in either group. No conversion to laparotomy was
necessary.
With regard to the early postoperative outcome (Table 3),
the mean discharge time was longer with LAVH than with
VH (724.8 vs 482.4 hours; P0.000). Neither operating
time nor blood loss had any effect on the discharge time
considered as a dependent variable in the GLM analysis
(P0.05). The paralytic ileus time was significantly shorter
after VH (193v s2 6 3h ;P 0.00). The operating time
had an influence on the paralytic ileus time considered as
a dependent variable in the GLM analysis (P0.00). Re-
garding the postoperative pain intensity at 24 hours, 20
patients (50%) reported absence of pain (VAS0) after
VH, and 6 (15%) after LAVH. Patients undergoing LAVH
had more postoperative pain compared with patients un-
dergoing VH. Postoperative fever was observed only in
one woman after LAVH. No early postoperative compli-
cations requiring readmission, blood transfusion, or re-
peat surgery were observed in either group.
Table 1.
Patient Characteristics
VH (n  40) LAVH (n  40) P
Age (years)* 48.8  0.7 48  0.5 0.60
BMI* 25.4  0.6 25.8  0.6 0.84
Parity* 2.2  0.2 2.1  0.2 0.86
Uterine weight (g)* 320  17 335  18 0.80
*Mean  SD.
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Our randomized trial aimed to compare the surgical and
immediate postoperative outcomes for vaginal hysterec-
tomy (VH) with those for laparoscopically assisted vaginal
hysterectomy (LAVH) in a series of patients with symp-
tomatic myomas and enlarged uterus. To eliminate even-
tual bias in our study, we adopted strict criteria for patient
selection for inclusion in the study. So, we excluded
nulliparous women and patients with previous uterine
surgery, such as caesarean delivery, which has been re-
ported to hinder vaginal surgery.16 Moreover, considering
the importance of the individual surgeon’s experience in
laparoscopic and vaginal surgery, all procedures were
performed by the same surgeons using the identical lapa-
roscopic and vaginal technique. In the LAVH group, the
level of laparoscopic assistance was decided a priori and
limited to the type ID (dissection up to but not including
uterine arteries  anterior structures and posterior cul-
dotomy) of laparoscopic assistance, according to the
AAGL Classification System for Laparoscopic Hysterecto-
my,15 ie, to evaluate the accessibility and mobility of the
uterus, to exclude the presence of problems, such as
adhesions, to secure the round ligaments, the ovarian or
infundibulopelvic ligaments, and to dissect the structures
located anterior and posterior to the uterus. Finally, we
included patients with uterine size between 12 and 16
weeks gestation to ensure homogeneity of the uterine
weight in the 2 groups.
In the literature, several studies report that operation time
is longer with LAVH than with VH.17–22 Also in our study,
the mean operating time was significantly shorter after VH
(P0.00), and this variable was strongly influenced by
intraoperative blood loss, particularly for the LAVH group.
Therefore, the set up for LAVH may cause a longer oper-
ative time than the set up for VH. Although other studies
reported controversial results,17,19,21 in our study the LAVH
group had more blood loss compared with VH (P0.00).
Considering that the uterine weight and the other surgical
factors were homogeneous in the 2 groups, and that the
uterine weight did not have any effect on the operating
time considered as a dependent variable in the GLM
analysis (P0.50), and on the blood loss (P0.05), it is
difficult to explain this finding. It is not clear whether the
laparoscopic or transvaginal route is better for the division
of the uterine vessels. Some authors observed less bleed-
ing during the vaginal step when the uterine vessels were
transected laparoscopically.23,24 On the other hand, the
transvaginal approach may be associated with retrograde
bleeding, especially when a uterine morcellation is nec-
essary.25–27 So, the approach to the uterine vessels, vaginal
or laparoscopic, could explain the different blood loss in
the various studies. To elucidate this issue, it would be
interesting to compare the blood loss associated with type
I (not involving laparoscopic occlusion and division of the
uterine arteries) and type II (involving laparoscopic oc-
clusion and division of the uterine arteries) LAVH.15
With regard to the early postoperative outcome, the par-
alytic ileus time was significantly shorter after VH
(P0.00). This finding could be explained with the shorter
operation time in the VH group taking into account that
the operating time had an influence on the paralytic ileus
time considered as a dependent variable in the GLM
analysis (P0.00). The mean discharge time was signifi-
cantly longer with LAVH than with VH (P0.000). Neither
the operating time nor the blood loss had any direct effect
on the discharge time considered a dependent variable in
the GLM analysis (P0.05), but the longer paralytic ileus
time could have influenced the longer discharge time with
LAVH. Postoperative pain was greater in patients under-
going LAVH than those undergoing VH, probably because
of the pneumoperitoneum and the small abdominal inci-
sions.
Table 2.
Operative Data
VH (n  40) LAVH (n  40) P†
Operating time (min)* 71  3 129  7 0.000
Blood loss (mL)* 186.0  52 362.7  65 0.000
Conversion to
laparotomy, No. (%) 0 (0) 0 (0) NS
Intraoperative
complications, No. (%) 0 (0) 0 (0) NS
*Mean  SD.
†NS  not significant.
Table 3.
Early Postoperative Outcomes
VH (n  40) LAVH (n  40) P†
Paralytic ileus time (h)* 19  32 6  3 0.000
Discharge time (h)* 48  2.6 72  4.2 0.000
Postoperative
complications, No. (%)
0 (0) 0 (0) NS
*Mean  SD.
†NS  not significant.
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methods of hysterectomy are discordant. Some authors
found a longer discharge time with LAVH,20 while other
studies showed comparable discharge times with the 2
methods.1,17,19,22 The different discharge criteria applied in
the diverse studies could justify these discrepancies. In
our study, for example, rigid criteria were adopted, so the
patients returned home only when they were tolerant of a
normal diet, able to dress themselves, fully mobile, apyr-
exial, and not requiring analgesics.
In the literature, the review of the major reports on hys-
terectomy for myomatous uteri demonstrates that the vag-
inal approach is used more frequently for small- or medi-
um-sized uteri. With the LAVH, the abdominal-pelvic
exploration and the ability to perform oophorectomy
safely represent the major advantages compared with VH.
The specific indications for each of the hysterectomy tech-
niques remain uncertain. However, the purpose of LAVH
and total laparoscopic hysterectomy is not to replace VH,
but rather to increase the abilities of the gynecological
surgeon to perform minimally invasive surgery for more
extended indications, avoiding the need of an abdominal
hysterectomy also in the presence of ovarian tumors,
tubo-ovarian adhesions, endometriosis, or previous pelvic
surgery. Although the selected surgical technique is es-
sentially based on the surgeons’ experience, all the pa-
tients must be informed about the various feasible surgical
alternatives, and about their respective risks and benefits.
CONCLUSION
Several surgical and immediate postoperative outcomes
were significantly better in the VH group than in the LAVH
group. However, further controlled prospective studies
are required to identify the best approach for hysterec-
tomy in patients with enlarged myomatous uterus.
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